Chris Smalley has recently retired from Merck, where he had responsibility for innovative implementation and validation, including Single Use Systems, globally. Previously, he had been Director of Quality Operations for Wyeth Pharmaceuticals for 12 years with responsibility for setting validation standards and validation activities globally. His research experience includes responsibility for Quality in the U.S. operations of the Sanofi Research Division, and earlier he had worked for the Johnson & Johnson family of companies, where he was a Plant Manager. Chris is a graduate of the Philadelphia College of Pharmacy of the University of the Sciences in Philadelphia. His graduate education includes a MBA from Temple University Fox School of Business, a Masters of Science in Pharmaceutical Chemistry from Temple University School of Pharmacy, and a Ph.D. in Healthcare Administration from LaSalle University.
Chris is currently a member of the ISPE Disposables CoP, and serves on the Pharmaceutical Engineering Committee (PEC).